In last trading session, Ocular Therapeutix Inc (NASDAQ:OCUL) saw 1.86 million shares changing hands with its beta currently measuring 1.53. Company’s recent per share price level of $7.34 trading at $0.8 or 12.23% at ring of the bell on the day assigns it a market valuation of $1.17B. That closing price of OCUL’s stock is at a discount of -60.35% from its 52-week high price of $11.77 and is indicating a premium of 44.69% from its 52-week low price of $4.06. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.72 million shares which gives us an average trading volume of 1.27 million if we extend that period to 3-months.
For Ocular Therapeutix Inc (OCUL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Ocular Therapeutix Inc (NASDAQ:OCUL) trade information
Upright in the green during last session for gaining 12.23%, in the last five days OCUL remained trading in the red while hitting it’s week-highest on Thursday, 03/27/25 when the stock touched $7.34 price level, adding 8.71% to its value on the day. Ocular Therapeutix Inc’s shares saw a change of -14.05% in year-to-date performance and have moved -4.30% in past 5-day. Ocular Therapeutix Inc (NASDAQ:OCUL) showed a performance of 12.92% in past 30-days. Number of shares sold short was 12.83 million shares which calculate 8.44 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 19 to the stock, which implies a rise of 61.37% to its current value. Analysts have been projecting 19 as a low price target for the stock while placing it at a high target of 19. It follows that stock’s current price would drop -158.86% in reaching the projected high whereas dropping to the targeted low would mean a loss of -158.86% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 8.51% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 0.74% while estimates for its earnings growth in next 5 years are of 4.84%.
Ocular Therapeutix Inc (NASDAQ:OCUL)’s Major holders
Insiders are in possession of 1.01% of company’s total shares while institution are holding 85.24 percent of that, with stock having share float percentage of 86.11%. Investors also watch the number of corporate investors in a company very closely, which is 85.24% institutions for Ocular Therapeutix Inc that are currently holding shares of the company. SUMMER ROAD LLC is the top institutional holder at OCUL for having 14.89 million shares of worth $101.82 million. And as of 2024-06-30, it was holding 8.9767 of the company’s outstanding shares.
The second largest institutional holder is VR ADVISER, LLC, which was holding about 12.76 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.6964 of outstanding shares, having a total worth of $87.3 million.
